G. Krivoborodov

发表

AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2)

M. Volteau, P. Denys, M. Kennelly, 2022, Neurourology and urodynamics.

Efficacy and safety of repeated dosing of netupitant, a neurokinin‐1 receptor antagonist, in treating overactive bladder

C. Pietra, F. Haab, B. Braticevici, 2014, Neurourology and urodynamics.

Percutaneous/Transcutaneous Tibial Nerve Stimulation

G. Krivoborodov, 2019, Neurourology.

[Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease].

A. Gekht, G. Krivoborodov, E. Korshunova, 2006, Urologiia.

Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus

T. Popkova, V. Simanenkov, D. Andreev, 2021, Cardiovascular Therapy and Prevention.

[Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia].

N. S. Efremov, A. D. Bolotov, G. Krivoborodov, 2017, Urologiia.

Trospium chloride in older patients with idiopathic overactive urinary badder

O. Tkacheva, N. S. Efremov, A. Gontar, 2022, Russian Journal of Geriatric Medicine.

Lower urinary tract symptoms in men

T. Wilt, J. Hollingsworth, G. Krivoborodov, 2014, BMJ : British Medical Journal.

[Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians].

A. Karateev, V. Simanenkov, I. Maev, 2022, Terapevticheskii arkhiv.

[Socio-economic aspects of neurogenic dysfunctions in urology].

R. V. Stroganov, G. Kasyan, R. V. Salyukov, 2020, Urologiia.

Percutaneous and transcutaneous tibial nerve stimulation in treatment of patients with overactive bladder without detrusor overactivity, refractory to antimuscarinics.

E. Tur, Efremov Ns, G. Krivoborodov, 2017 .